Immunotoxins: A New Approach to Cancer Therapy
- 11 February 1983
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 219 (4585), 644-650
- https://doi.org/10.1126/science.6218613
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody–ricin conjugateNature, 1982
- In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.The Journal of Experimental Medicine, 1982
- Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin.The Journal of Experimental Medicine, 1982
- Monoclonal Antibody‐Ricin or Ricin A Chain Hybrids: Kinetic Analysis of Cell Killing for Tumor TherapyImmunological Reviews, 1982
- Selective killing of leukaemia cells by antibody–toxin conjugates: implications for autologous bone marrow transplantationNature, 1982
- Preparation of a hybrid of fragment Fab' of antibody and fragment a of diphtheria toxin and its cytotoxicityBiochemical and Biophysical Research Communications, 1979
- Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.The Journal of Experimental Medicine, 1978
- Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes.The Journal of Experimental Medicine, 1976
- Different biological properties of the two constituent peptide chains of ricin a toxic protein inhibiting protein synthesisBiochemistry, 1973
- The carrier effect in the secondary response to hapten‐protein conjugates. V. Use of antilymphocyte serum to deplete animals of helper cellsEuropean Journal of Immunology, 1971